核心提示：日本大阪2010年8月23日电／美通社亚洲／ －－Hospira Japan Co．， Ltd． 今天宣布，该公司已获批可长时间（超过24小时）使用镇静药“Precedex IV（TM）200ug”（通用名：盐酸右美托咪定）。此次获批前，Hospira 已于今年早些时候首次在加拿大和韩国推出 ...

Shares of Hospira (HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company’s decision to file a lawsuit against the FDA over approvals granted to generic ...

Shares of Hospira ( HSP) tumbled 2.81% to close the trading session on Aug 19 at $53.92 per share, following the company's decision to file a lawsuit against the FDA over approvals granted to generic ...

Dexmedetomidine HCl in 0.9% NaCl; 4mcg/mL; soln for IV infusion. Precedex (dexmedetomidine hydrochloride) injection 200 mcg/2 mL (100 mcg/mL) is clear and colorless. The strength is based on the ...

Drug maker Hospira Inc. took the unusual step of filing a lawsuit to challenge the U.S. Food and Drug Administration's approval this week of generic copies of the company's best-selling product, the ...

The US Food and Drug Administration’s Office of Prescription Drug Promotion has hit Pfizer subsidiary Hospira with an untitled letter over the company's "misleading" YouTube video on its sedative ...

LAKE FOREST, Ill., March 18, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the U.S. Food and Drug ...

The FDA has approved Precedex (dexmedetomidine HCl, from Hospira) injection for the sedation of non-intubated patients prior to and/or during surgical and other procedures. This approval is based on ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Orion Corporation ("Orion") together with Hospira, Inc. ("Hospira") and Sandoz Inc. and Sandoz Canada Inc. (hereinafter collectively "Sandoz") have amended the settlement agreement published on 5 ...

Originally, Precedex was approved in Japan in 2004 for sedation of initially intubated and mechanically ventilated patients in the intensive care setting for use up to 24 hours. However, some ...

ORION CORPORATION STOCK EXCHANGE RELEASE 21 OCTOBER 2013 at 8:10 p.m. EEST Orion Corporation and Hospira, Inc. have extended their licensing agreement concerning the sedative agent Precedex® in the ...